Novelix Pharmaceuticals Ltd - 536565 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Novelix Pharmaceuticals' promoters and promoter group acquired 14.85 lakh equity shares for Rs. 2.97 crore through a preferential allotment on July 9, 2026. This transaction increased their combined shareholding from 45.34% to 49.90%.
Jul 13 2026 18:39:14
Novelix Pharmaceuticals Ltd - 536565 - Announcement under Regulation 30 (LODR)-Allotment
Novelix Pharmaceuticals Limited allotted 45.75 lakh equity shares, comprising 33.75 lakh shares from warrant conversion and 12 lakh shares via preferential issue. The company raised a total of Rs. 13.59 crore from these allotments.
Jul 10 2026 13:01:23
Novelix Pharmaceuticals Ltd - 536565 - Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E. Thursday, 09Th July, 2026
Novelix Pharmaceuticals Limited approved the allotment of 45.75 lakh equity shares. This includes 33.75 lakh shares to promoter group at Rs. 20 each via warrant conversion and 12 lakh shares to non-promoters at Rs. 57 each through a preferential issue. The company raised a total of Rs. 11.9 crore, increasing its paid-up equity capital to 28.47 million shares.
Jul 09 2026 19:27:39
Novelix Pharmaceuticals Ltd - 536565 - Shareholders Meeting - EGM- Voting Results
Novelix Pharmaceuticals' shareholders have approved the special resolution for the preferential issue of equity shares at the Extra-ordinary General Meeting held on July 1, 2026. This approval indicates the company's intent to raise capital through equity.
Jul 02 2026 18:34:13
Novelix Pharmaceuticals Ltd - 536565 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Novelix Pharmaceuticals' shareholders have approved the special resolution for the preferential issue of equity shares at the Extra-ordinary General Meeting held on July 1, 2026. This approval indicates the company's intent to raise capital through equity.
Jul 02 2026 18:32:23
Novelix Pharmaceuticals Ltd - 536565 - Shareholder Meeting / Postal Ballot-Outcome of EGM
Trimurthi's Extraordinary General Meeting (EGM) on July 1, 2026, approved the resolution for issuing equity shares on a preferential basis. This decision authorizes the company to proceed with capital raising.
Jul 01 2026 17:09:56
Novelix Pharmaceuticals Ltd - 536565 - Shareholders Meeting- Corrigendum To The EGM Notice Of The EGM Scheduled To Be Held On 01St July, 2026.
Novelix Pharmaceuticals issued a corrigendum to its EGM notice for July 01, 2026. The update modifies the list of proposed allottees for the preferential issue after two individuals were disqualified for violating SEBI ICDR Regulations, leading to the re-allocation of 175,000 shares.
Jun 17 2026 17:43:09
Read More